
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Jean-Frederic Colombel, MD
Gastroenterology
About Me
Jean-Frederic Colombel, MD, is the Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at the Icahn School of Medicine at Mount Sinai. Since 1984, his research has focused on IBD, and thanks to the development of multiple local, national, and international collaborations, he has been able to contribute to important advances in the pathophysiology of the disease. He is past president of the GETAID, European Crohn’s and Colitis Organization and past chair of International Organization for Inflammatory Bowel Disease (IOIBD).
Dr. Colombel was awarded the United European Gastroenterology Federation Research Prize in 2009, the Crohn’s and Colitis Foundation Clinical Research Award in 2014, the Sherman Prize in 2018 and the Jacobi Medallion in 2022. One tangible result of Dr. Colombel’s work has been the publication as primary author or co-author of more than 1,100 peer-reviewed papers with an H index of 185.
Language
English, French
Position
PROFESSOR | Medicine, Gastroenterology, PROFESSOR | Immunology & Immunotherapy
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Celiac Disease
- Crohn's Disease
- Flexible Sigmoidoscopy
- Gastroenterology
- Inflammatory Bowel Disease
- Ulcerative Colitis
Video
Education
MD, Universite Picardie
Fellowship, Transplant Hepatology
Hospital Center University De Lille
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) please click here for more information. Patients with Molina insurance should click here for more information. Mount Sinai’s contracts with Anthem and Molina expired on December 31.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary. Nicolas Barnich, Janelle C. Arthur, Anthony Buisson, Barry J. Campbell, Franck Carbonnel, Benoit Chassaing, Brian K. Coombes, Jérémy Denizot, Belgin Dogan, Jeremiah Faith, Nobuhiko Kamada, Randy S. Longman, Margarita Martinez-Medina, Claire L. O'Brien, R. Balfour Sartor, Shiying Zhang, Jean Frederic Colombel, Kenneth W. Simpson, Agrawal Manasi, Ahn Ju-Hyun, Amani Souwelimatou, Arthur Janelle, Aurrand Candice, Barnich Nicolas, Billard Elisabeth, Bonet Rossinyol Queralt, Botchorichvilli Hélène, Buisson Anthony, Bustamante Paula, Campbell Barry, Carbonnel Franck, Cardakli Emre, Chassaing Benoit, Chevarin Caroline, Coombes Brian, Colombel Jean-Frederic, Silva Alison Da Silva Alison, Dambrine Flavie, Darwish Lena, Dauriat Charlene, Clercq Fanny De Clercq Fanny, Denizot Jérémy, Dogan Belgin, Evans Bethan, Faith Jeremiah, Falabregue Marion, Fargeas Margot, Faure Frédéric, Fernandez Coll Llorenc, Fiebig Aline. Gut
- A pilot genome-wide association study of collagen deposition in collagenous colitis. Biagio Di Lorenzo, Tenghao Zheng, Florian Rieder, Jean Frederic Colombel, Inga Peter, Juozas Kupcinskas, Bodil Ohlsson, Carme Ferrer Cassado, Yamile Zabana, Andreas Münch, Dainius Jančiauskas, Ilyssa O. Gordon, Mauro D’Amato, Giulia Roda. Gastroenterology Report
- Cross-Sectional Imaging Features Associated With Disease Progression in Crohn’s Disease. Salam P. Bachour, Shravya Srinivas-Rao, Nikitha Uma Baskaran, Manasi Agrawal, Henrik Albaek Jacobsen, Lone Larsen, Tine Jess, Jean Frederic Colombel, Ryan C. Ungaro, Avinash Kambadakone, Ashwin N. Ananthakrishnan. Inflammatory Bowel Diseases
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Dr colombel is an excellent, capable Dr. I trust his instincts.
Had an excellent first experience w Dr Colombel as well as his assistants and supporting staff. He was very curious to learn, asked questions, and also provided context and explanation. He is clearly very enthusiastic about serving his patients.
Dr. Colombel is always there for me helping me fight this horrible disease, I thank god for him every day.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Colombel during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Protagonist Therapeutics, Inc.
- Envision Pharma
- Immunic
- GlaxoSmithKline
- Pfizer Inc.
- Shire
- Ferring Pharmaceuticals
- Boehringer Ingelheim Corporation
- Anapty Bio
- Boxer
- Eli Lilly and Company
- Ensho
- Merck & Co., Inc.
- Microbia Novartic
- Landos
- Alimentiv
- Tigenix
- Celgene Corporation
- Teva
- Amgen Inc.
- Sanofi
- Takeda Pharmaceuticals International GmbH
- Otsuka Pharmaceutical Co., Ltd.
- Bristol-Myers Squibb
- WEBMD Health Corp
- Integritas Communication
- Prometheus Laboratories Inc.
- AbbVie Inc.
- Sun
- Arena
- Imedex, LLC.
- Seres
- Allergan, Inc.
- Genentech, Inc.
- Janssen Pharmaceuticals, Inc.
- Union Therapeutics A/S
- Iterative Scope
- Vifor
- Galmed research
- Guide Point
- Kaleido
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Intestinal Biotech Development
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.